Table 2.
Muscle performance and functional performance measures.
| Biodex Muscle Performance Measures | |||||
|---|---|---|---|---|---|
| Variable | Controls (N=22) | DM (N=10) | DMPN (N=47) | F-statistic P-value | Post-Hoc |
| PF peak torque 60/sec (Nm) | 61±27 | 43±9 | 47±16 | p=.02* |
+(p=.01) #(p=.02) |
| PF power 60/sec (Watts) | 48±23 | 35±8 | 39±16 | p=.06 | |
| PF work 60/sec (Nm) | 37±16 | 30±16 | 26±12 | p=.21 | |
| PF peak torque 120/sec | 56±22 | 46±11 | 41±14 | p=.07 | |
| PF torque per unit muscle volume (Nm/cm3) | .24±.11 | .17±.06 | .23±.09 | p=.18 | |
| PF power 120/sec | 94±30 | 64±19 | 64±24 | p=.02* |
+ (p=.01) # (p=.02) |
| DF peak torque 60/sec | 12±19 | 14±8 | 5±7 | p=.01* |
+(p=.02) ^(p=.02) |
| DF power 60/sec | 8±15 | 9±7 | 3±5 | p=.04* | + (p=.03) |
| DF torque per unit muscle volume | .18±.24 | .22±.16 | .09±.11 | p=.02* |
+(p=.04) ^(p=.01) |
| Functional Performance Measures** | |||||
|---|---|---|---|---|---|
| Variable | Controls (N=10) | DM (N=10) | DMPN (N=18) | F-statistic P-value | Post-Hoc |
| 9-item PPT (total score) | 34±1 | 32±2 | 29±4 | p=.003* | +(p=.002) |
| Chair Rise Time (seconds) | 12±2 | 14±2 | 18±6 | p=.004*∇ | +(p=.002) |
| Single Leg Balance (seconds) | 14±12 | 22±12 | 10±9 | p=.035* | ^(p=.02) |
| 6 minute walk (meters) | 1681±160 | 1467±274 | 1396±323 | p=.03* | +(p=.03) |
| Coin Pickup Time (seconds) | 1.9±.4 | 2.5±.9 | 3.2±1 | p=.01*∇ | +(p=.002) |
| Stair Power (Watts) | 809±327 | 660±176 | 633±219 | p=.18 | |
| Stair Climb Time (1-flight seconds) | 4±1 | 5±2 | 6±2 | p=.05*∇ | +(p=.01) |
| 50 ft walk time (seconds) | 10±1 | 11±2 | 12±2 | p=.03* | +(p=.02) |
Participant demographics were compared across groups using 1-way ANOVA.
denotes significant F-test indicating difference between groups,
denotes Games-Howell post-hoc for violation of homogeneity of variance.
The following symbols represent post-hoc pairwise comparisons:
(between T2DM and T2DMPN),
(between T2DMPN and Controls),
(between T2DM and controls).
(These analysis performed on a subgroup of 38 participants who completed these measures- see section 2 and 2.4.1–2.4.4).